The Cost-Effectiveness of Biologic Dmards in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional Dmards
Value Health
.
2014 Nov;17(7):A380.
doi: 10.1016/j.jval.2014.08.2611.
Epub 2014 Oct 26.
Authors
A J Wailoo
1
,
M Stevenson
2
,
J Tosh
2
,
M Hernández
2
,
J W Stevens
2
,
R Archer
2
,
E Simpson
2
,
Hock E Everson
2
,
D Scott
3
,
A Young
4
,
S Paisley
5
,
K Williams
5
Affiliations
1
NICE Decision Support Uni, Sheffield, UK.
2
University of Sheffield, Sheffield, UK.
3
KCL, London, UK.
4
adam. young@nhs. net, Heertford, UK.
5
The University of Sheffield, Sheffield, UK.
PMID:
27200840
DOI:
10.1016/j.jval.2014.08.2611
No abstract available